Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certolizumab pegol breast milk transfer study in lactating mothers
NL-OMON41111Active, not recruiting
- Sponsor
- UCB
- Start
- Nov 2014
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of certolizumab pegol, sponsored by UCB. Started Nov 2014; status: active, not recruiting.
02
Drugs
certolizumab pegol
Beyond the preview
Go deeper on NL-OMON41111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41111.